EP3504229
REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.8.2017:
13.10.2021:
17844404.8
:
23.8.2037
:
REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES
24.8.2017
13.10.2021
:
Sangamo Therapeutics, Inc.:
7000 Marina Blvd, Brisbane, CA 94005, US
:
MILLER, Jeffrey C.:
Brisbane California 94005, US
:
REBAR, Edward J.:
Brisbane California 94005, US
:
201662378978 P:
24.8.2016:
US
:
201762443981 P:
9.1.2017:
US
:
201762545778 P:
15.8.2017:
US
:
US2017048397:
24.8.2017
:
A61K 35/28, A61K 38/00, A61P 7/00, A61P 7/06, C12N 9/22, C12N 15/90